These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

446 related items for PubMed ID: 27894359

  • 1. Can morphological MRI differentiate between primary central nervous system lymphoma and glioblastoma?
    Malikova H, Koubska E, Weichet J, Klener J, Rulseh A, Liscak R, Vojtech Z.
    Cancer Imaging; 2016 Nov 29; 16(1):40. PubMed ID: 27894359
    [Abstract] [Full Text] [Related]

  • 2. Primary central nervous system lymphoma and atypical glioblastoma: differentiation using the initial area under the curve derived from dynamic contrast-enhanced MR and the apparent diffusion coefficient.
    Choi YS, Lee HJ, Ahn SS, Chang JH, Kang SG, Kim EH, Kim SH, Lee SK.
    Eur Radiol; 2017 Apr 29; 27(4):1344-1351. PubMed ID: 27436023
    [Abstract] [Full Text] [Related]

  • 3. Primary central nervous system lymphoma and glioblastoma differentiation based on conventional magnetic resonance imaging by high-throughput SIFT features.
    Chen Y, Li Z, Wu G, Yu J, Wang Y, Lv X, Ju X, Chen Z.
    Int J Neurosci; 2018 Jul 29; 128(7):608-618. PubMed ID: 29183170
    [Abstract] [Full Text] [Related]

  • 4. Differentiation between primary CNS lymphoma and glioblastoma: qualitative and quantitative analysis using arterial spin labeling MR imaging.
    You SH, Yun TJ, Choi HJ, Yoo RE, Kang KM, Choi SH, Kim JH, Sohn CH.
    Eur Radiol; 2018 Sep 29; 28(9):3801-3810. PubMed ID: 29619520
    [Abstract] [Full Text] [Related]

  • 5. Central nervous system lymphoma: a morphological MRI study.
    Koubska E, Weichet J, Malikova H.
    Neuro Endocrinol Lett; 2016 Sep 29; 37(4):318-324. PubMed ID: 27857050
    [Abstract] [Full Text] [Related]

  • 6. Differentiating between Glioblastoma and Primary CNS Lymphoma Using Combined Whole-tumor Histogram Analysis of the Normalized Cerebral Blood Volume and the Apparent Diffusion Coefficient.
    Bao S, Watanabe Y, Takahashi H, Tanaka H, Arisawa A, Matsuo C, Wu R, Fujimoto Y, Tomiyama N.
    Magn Reson Med Sci; 2019 Jan 10; 18(1):53-61. PubMed ID: 29848919
    [Abstract] [Full Text] [Related]

  • 7. Diagnostic utility of intravoxel incoherent motion mr imaging in differentiating primary central nervous system lymphoma from glioblastoma multiforme.
    Yamashita K, Hiwatashi A, Togao O, Kikuchi K, Kitamura Y, Mizoguchi M, Yoshimoto K, Kuga D, Suzuki SO, Baba S, Isoda T, Iwaki T, Iihara K, Honda H.
    J Magn Reson Imaging; 2016 Nov 10; 44(5):1256-1261. PubMed ID: 27093558
    [Abstract] [Full Text] [Related]

  • 8. Machine learning applications for the differentiation of primary central nervous system lymphoma from glioblastoma on imaging: a systematic review and meta-analysis.
    Nguyen AV, Blears EE, Ross E, Lall RR, Ortega-Barnett J.
    Neurosurg Focus; 2018 Nov 01; 45(5):E5. PubMed ID: 30453459
    [Abstract] [Full Text] [Related]

  • 9. MR imaging based fractal analysis for differentiating primary CNS lymphoma and glioblastoma.
    Liu S, Fan X, Zhang C, Wang Z, Li S, Wang Y, Qiu X, Jiang T.
    Eur Radiol; 2019 Mar 01; 29(3):1348-1354. PubMed ID: 30167811
    [Abstract] [Full Text] [Related]

  • 10. Differences between primary central nervous system lymphoma and glioblastoma: topographic analysis using voxel-based morphometry.
    Yamashita K, Hiwatashi A, Togao O, Kikuchi K, Momosaka D, Hata N, Akagi Y, Suzuki SO, Iwaki T, Iihara K, Honda H.
    Clin Radiol; 2019 Oct 01; 74(10):816.e1-816.e8. PubMed ID: 31400805
    [Abstract] [Full Text] [Related]

  • 11. Primary central nervous system lymphoma and atypical glioblastoma: Differentiation using radiomics approach.
    Suh HB, Choi YS, Bae S, Ahn SS, Chang JH, Kang SG, Kim EH, Kim SH, Lee SK.
    Eur Radiol; 2018 Sep 01; 28(9):3832-3839. PubMed ID: 29626238
    [Abstract] [Full Text] [Related]

  • 12. What is the Best Preoperative Quantitative Indicator to Differentiate Primary Central Nervous System Lymphoma from Glioblastoma?
    Inoue A, Matsumoto S, Ohnishi T, Miyazaki Y, Kinnami S, Kanno K, Honda T, Kurata M, Taniwaki M, Kusakabe K, Suehiro S, Yamashita D, Shigekawa S, Watanabe H, Kitazawa R, Kunieda T.
    World Neurosurg; 2023 Apr 01; 172():e517-e523. PubMed ID: 36690204
    [Abstract] [Full Text] [Related]

  • 13. Differentiating Glioblastoma from Primary Central Nervous System Lymphoma: The Value of Shaping and Nonenhancing Peritumoral Hyperintense Gyral Lesion on FLAIR Imaging.
    Wang P, Shi YH, Li JY, Zhang CZ.
    World Neurosurg; 2021 May 01; 149():e696-e704. PubMed ID: 33548537
    [Abstract] [Full Text] [Related]

  • 14. Multiparametric imaging-based differentiation of lymphoma and glioblastoma: using T1-perfusion, diffusion, and susceptibility-weighted MRI.
    Saini J, Kumar Gupta P, Awasthi A, Pandey CM, Singh A, Patir R, Ahlawat S, Sadashiva N, Mahadevan A, Kumar Gupta R.
    Clin Radiol; 2018 Nov 01; 73(11):986.e7-986.e15. PubMed ID: 30197047
    [Abstract] [Full Text] [Related]

  • 15. Primary brain lymphoma and glioblastoma: evaluation of DCE T1 and DSC T2 MRI perfusion findings.
    Soydan H, Sözmen Cılız D, Cesur T, Tezgör Aksakal E.
    Acta Radiol; 2024 Jul 01; 65(7):800-807. PubMed ID: 38798137
    [Abstract] [Full Text] [Related]

  • 16. Quantitative Evaluation of Diffusion and Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Differentiation Between Primary Central Nervous System Lymphoma and Glioblastoma.
    Lu S, Wang S, Gao Q, Zhou M, Li Y, Cao P, Hong X, Shi H.
    J Comput Assist Tomogr; 2017 Jul 01; 41(6):898-903. PubMed ID: 28806317
    [Abstract] [Full Text] [Related]

  • 17. MRI as a diagnostic biomarker for differentiating primary central nervous system lymphoma from glioblastoma: A systematic review and meta-analysis.
    Suh CH, Kim HS, Jung SC, Park JE, Choi CG, Kim SJ.
    J Magn Reson Imaging; 2019 Aug 01; 50(2):560-572. PubMed ID: 30637843
    [Abstract] [Full Text] [Related]

  • 18. The combination of 13N-ammonia and 18F-FDG in predicting primary central nervous system lymphomas in immunocompetent patients.
    Shi X, Zhang X, Yi C, Wang X, Chen Z, Zhang B.
    Clin Nucl Med; 2013 Feb 01; 38(2):98-102. PubMed ID: 23334122
    [Abstract] [Full Text] [Related]

  • 19. Does adding FDG-PET to MRI improve the differentiation between primary cerebral lymphoma and glioblastoma? Observer performance study.
    Makino K, Hirai T, Nakamura H, Murakami R, Kitajima M, Shigematsu Y, Nakashima R, Shiraishi S, Uetani H, Iwashita K, Akter M, Yamashita Y, Kuratsu J.
    Ann Nucl Med; 2011 Jul 01; 25(6):432-8. PubMed ID: 21404136
    [Abstract] [Full Text] [Related]

  • 20. Balanced transformer: efficient classification of glioblastoma and primary central nervous system lymphoma.
    Wang S, Wu J, Chen M, Huang S, Huang Q.
    Phys Med Biol; 2024 Feb 15; 69(4):. PubMed ID: 38232389
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.